Table 5.
Safety analysis results of two groups of patients with knee arthritis.
| Adverse events |
Total (N = 250) |
Flurbiprofen (N = 125) |
Loxoprofen (N = 125) |
P-value |
|---|---|---|---|---|
| Overall adverse events | 49 (19.6) | 7 (5.6) | 42 (33.6) | <0.001 |
| Skin irritation | 16 (6.4) | 4 (3.2) | 12 (9.6) | 0.039 |
| Skin rash | 15 (6.0) | 2 (1.6) | 13 (10.4) | 0.003 |
| Skin pain | 11 (4.4) | 2 (1.6) | 9 (7.2) | 0.031 |
| Sticky hair uncovering pain | 36 (14.4) | 1 (0.8) | 35 (28.0) | <0.001 |
| Adverse event severity score* | 0 (0–1.0) | 0 (0) | 0 (0–1.0) | <0.001 |
Data are presented as n (%) and median (interquartile range). *The severity of each adverse event was measured using a scale ranging from 0 to 4, with higher points indicating more severe conditions.